Lista de obras - Christopher E. Barbieri - Dominio Público Uruguay

Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.

artículo científico publicado en 2014

Clinical variability and molecular heterogeneity in prostate cancer

artículo científico publicado en 2016

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.

artículo científico publicado en 2017

DNA Repair in Prostate Cancer: Biology and Clinical Implications

artículo científico publicado en 2016

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial

scientific article published on 18 August 2011

Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

artículo científico publicado en 2016

Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway.

artículo científico publicado en 2003

DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis

artículo científico publicado en 2009

Editorial Comment

artículo científico publicado en 2016

Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial

artículo científico publicado en 2015

Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations

artículo científico publicado en 2017

Evidence for molecular differences in prostate cancer between African American and Caucasian men

artículo científico publicado en 2014

Evolution of novel biomarkers for detection of prostate cancer

artículo científico publicado en 2013

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

artículo científico publicado en 2012

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer

artículo científico publicado en 2021

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

artículo científico publicado en 2018

Genomic rearrangements in prostate cancer

artículo científico publicado en 2015

IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium

artículo científico publicado en 2005

Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.

artículo científico

Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells

artículo científico publicado en 2003

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

artículo científico publicado en 2020

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

artículo científico publicado en 2016

Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis

artículo científico publicado en 2006

Molecular Characterization of Prostate Cancer Following Androgen Deprivation: The Devil in the Details

artículo científico publicado en 2013

Molecular genetics of prostate cancer: emerging appreciation of genetic complexity

artículo científico

Molecular subtyping of prostate cancer

artículo científico publicado en 2016

Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium

artículo científico publicado en 2012

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.

artículo científico publicado en 2016

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

artículo científico publicado en 2017

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

artículo científico publicado en 2013

Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.

artículo científico publicado en 2016

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

scientific article published on 01 July 2019

Punctuated evolution of prostate cancer genomes

artículo científico publicado en 2013

Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.

artículo científico publicado en 2017

Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456.

artículo científico publicado en 2013

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

artículo científico publicado en 2014

Reprint of: The prostate cancer genome: Perspectives and potential.

artículo científico

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.

artículo científico publicado en 2017

SPOP mutation leads to genomic instability in prostate cancer.

artículo científico publicado en 2015

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

artículo científico publicado en 2014

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

artículo científico publicado en 2018

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

artículo científico publicado en 2015

Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.

artículo científico publicado en 2011

TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia

artículo científico publicado en 2013

The DNA binding activity of p53 displays reaction-diffusion kinetics.

artículo científico publicado en 2006

The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics

artículo científico publicado en 2016

The Lethal Clone in Prostate Cancer: Redefining the Index

artículo científico publicado en 2014

The long tail of oncogenic drivers in prostate cancer.

artículo científico publicado en 2018

The mutational landscape of prostate cancer

artículo científico publicado en 2013

The prostate cancer genome: perspectives and potential.

artículo científico publicado en 2013

Unraveling the clonal hierarchy of somatic genomic aberrations.

artículo científico publicado en 2014

Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.

artículo científico publicado en 2010

Lista de obras de Christopher E. Barbieri

Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.

Clinical variability and molecular heterogeneity in prostate cancer

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.

DNA Repair in Prostate Cancer: Biology and Clinical Implications

Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial

Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.

Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway.

DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis

Editorial Comment

Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial

Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations

Evidence for molecular differences in prostate cancer between African American and Caucasian men

Evolution of novel biomarkers for detection of prostate cancer

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

Genomic rearrangements in prostate cancer

IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium

Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.

Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

Lethal Prostate Cancer in the PLCO Cancer Screening Trial.

Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis

Molecular Characterization of Prostate Cancer Following Androgen Deprivation: The Devil in the Details

Molecular genetics of prostate cancer: emerging appreciation of genetic complexity

Molecular subtyping of prostate cancer

Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium

Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial.

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

Punctuated evolution of prostate cancer genomes

Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.

Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456.

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment

Reprint of: The prostate cancer genome: Perspectives and potential.

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.

SPOP mutation leads to genomic instability in prostate cancer.

SPOP mutations in prostate cancer across demographically diverse patient cohorts.

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.

TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia

The DNA binding activity of p53 displays reaction-diffusion kinetics.

The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics

The Lethal Clone in Prostate Cancer: Redefining the Index

The long tail of oncogenic drivers in prostate cancer.

The mutational landscape of prostate cancer

The prostate cancer genome: perspectives and potential.

Unraveling the clonal hierarchy of somatic genomic aberrations.

Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.